Iovance Biotherapeutics, Inc.
NASDAQIovance Biotherapeutics heads into the week with a contradictory setup — short interest has fallen sharply over the past month, yet options traders are showing the most defensive tilt in months at the same time the stock slides back toward multi-month lows. The positioning story is defined by that divergence. Short interest has dropped dramatically, falling roughly 23% over the…
Snapshot as of 6 Aug 2026
Iovance Biotherapeutics heads into the week with a contradictory setup — short interest has fallen sharply over the past month, yet options traders are showing the most defensive tilt in months at the same time the…
Iovance Biotherapeutics heads into its August 6 earnings print with short sellers largely dug in — covering has stalled, the stock has given back its momentum, and options traders are quietly turning more…
Iovance Biotherapeutics enters the week of July 18 carrying one of the more interesting tensions in small-cap biotech: a stock up 31% in a month, yet still carrying 26% of its free float sold short — and shorts have…
Iovance Biotherapeutics enters its June 10 earnings week carrying one of the most polarised positioning profiles in small-cap biotech: short sellers anchored at a structurally high level, yet options traders have swung…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IOVA — free to start on ORTEX.
Sign up for free →Open IOVA on ORTEX